- Home
- STEM vs MIST Comparison
STEM vs MIST Comparison
Compare STEM & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- MIST
- Stock Information
- Founded
- STEM 2009
- MIST 2003
- Country
- STEM United States
- MIST Canada
- Employees
- STEM N/A
- MIST N/A
- Industry
- STEM Computer Software: Prepackaged Software
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- STEM Technology
- MIST Health Care
- Exchange
- STEM Nasdaq
- MIST Nasdaq
- Market Cap
- STEM 121.5M
- MIST 132.5M
- IPO Year
- STEM N/A
- MIST N/A
- Fundamental
- Price
- STEM $13.52
- MIST $1.75
- Analyst Decision
- STEM Hold
- MIST Strong Buy
- Analyst Count
- STEM 7
- MIST 2
- Target Price
- STEM $10.86
- MIST $7.50
- AVG Volume (30 Days)
- STEM 240.0K
- MIST 1.1M
- Earning Date
- STEM 10-29-2025
- MIST 08-12-2025
- Dividend Yield
- STEM N/A
- MIST N/A
- EPS Growth
- STEM N/A
- MIST N/A
- EPS
- STEM N/A
- MIST N/A
- Revenue
- STEM $156,002,000.00
- MIST N/A
- Revenue This Year
- STEM $11.45
- MIST N/A
- Revenue Next Year
- STEM $18.03
- MIST N/A
- P/E Ratio
- STEM N/A
- MIST N/A
- Revenue Growth
- STEM N/A
- MIST N/A
- 52 Week Low
- STEM $5.81
- MIST $0.63
- 52 Week High
- STEM $33.60
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- STEM 45.09
- MIST 53.57
- Support Level
- STEM $13.47
- MIST $1.75
- Resistance Level
- STEM $17.21
- MIST $1.83
- Average True Range (ATR)
- STEM 1.23
- MIST 0.08
- MACD
- STEM -0.39
- MIST 0.01
- Stochastic Oscillator
- STEM 3.36
- MIST 45.61
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).